Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial

Arina J. ten Cate-Hoek, Elham E. Amin, Annemieke C. Bouman, Karina Meijer, Lidwine W. Tick, Saskia Middeldorp, Guy J. M. Mostard, Marije ten Wolde, Simone M. van den Heiligenberg, Sanne van Wissen, Marlene H. W. van de Poel, Sabina Villalta, Erik H. Serne, Hans-Martin Otten, Edith H. Klappe, Ingrid M. Bistervels, Mandy N. Lauw, Margriet Piersma-Wichers, Paolo Prandoni, Manuela A. JooreMartin H. Prins, Hugo ten Cate, IDEAL DVT Investigators

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)25-33
Number of pages9
JournalThe Lancet Haematology
Volume5
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • DEEP VENOUS THROMBOSIS
  • QUALITY-OF-LIFE
  • VEIN THROMBOSIS
  • ANTITHROMBOTIC THERAPY
  • STOCKINGS
  • DISEASE
  • COMPLICATIONS
  • TRANSLATION
  • VALIDATION
  • DISORDERS

Cite this

ten Cate-Hoek, A. J., Amin, E. E., Bouman, A. C., Meijer, K., Tick, L. W., Middeldorp, S., Mostard, G. J. M., ten Wolde, M., van den Heiligenberg, S. M., van Wissen, S., van de Poel, M. H. W., Villalta, S., Serne, E. H., Otten, H-M., Klappe, E. H., Bistervels, I. M., Lauw, M. N., Piersma-Wichers, M., Prandoni, P., ... IDEAL DVT Investigators (2018). Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. The Lancet Haematology , 5(1), 25-33. https://doi.org/10.1016/S2352-3026(17)30227-2